Bleselumab is under investigation in clinical trial NCT02921789 (study to assess the efficacy and safety of Bleselumab in preventing the recurrence of focal segmental glomerulosclerosis in de novo kidney transplant recipients).
Applications:Suitable for use in ELISA and SDS-PAGE.
Other applications not tested.
Recommended Dilution:Optimal dilutions to be determined by the researcher.
Storage and Stability:May be stored at 4℃ for short-term only.
Aliquot to avoid repeated freezing and thawing.
Store at -20℃.
Aliquots are stable for 12 months after receipt.
For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
